Cite
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
MLA
Yamagata, Michiko, et al. “Fulminant B Hepatitis in a Surface Antigen and Hepatitis B DNA-Negative Patient with Diffuse Large B-Cell Lymphoma after CHOP Chemotherapy plus Rituximab.” Leukemia & Lymphoma, vol. 48, no. 2, Feb. 2007, pp. 431–33. EBSCOhost, https://doi.org/10.1080/10428190601059704.
APA
Yamagata, M., Murohisa, T., Tsuchida, K., Okamoto, Y., Tsunoda, S., Nakamura, M., Kusano, K., Majima, Y., Kuniyoshi, T., Iijima, M., Sugaya, H., & Hiraishi, H. (2007). Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab. Leukemia & Lymphoma, 48(2), 431–433. https://doi.org/10.1080/10428190601059704
Chicago
Yamagata, Michiko, Toshimitsu Murohisa, Kohei Tsuchida, Yutaka Okamoto, Saburo Tsunoda, Masae Nakamura, Koji Kusano, et al. 2007. “Fulminant B Hepatitis in a Surface Antigen and Hepatitis B DNA-Negative Patient with Diffuse Large B-Cell Lymphoma after CHOP Chemotherapy plus Rituximab.” Leukemia & Lymphoma 48 (2): 431–33. doi:10.1080/10428190601059704.